People · Operator
Named in public records as an officer, director or promoter · active 2016–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Gritstone bio, Inc. | — | Biotechnology | Series C | $100.0M | $763.5M | 2022 |
| Verge Analytics, Inc. | — | Biotechnology | Series C | $85.0M | $2.4B | 2021 |
| Cell Design Labs, Inc. | — | Biotechnology | Series B | $26.9M | $158.8M | 2016 |
| Revitope Oncology, Inc. | — | Biotechnology | Series A | $13.4M | $296.4M | 2016 |
Andrew Allen at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew Allen on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Beth Seidenberg | 1 | 15 |
| Brook Byers | 1 | 13 |
| Fred Cohen | 1 | 12 |
| Emily Melton | 1 | 10 |
| Judith Li | 1 | 8 |
| Brian Atwood | 1 | 6 |
| Peter Emtage | 1 | 2 |
| Mark Cobbold | 1 | 2 |
| Julie Cherrington | 1 | 2 |
| Raj Mehta | 1 | 2 |
| Greg Giotta | 1 | 1 |
| Arie Belldegrun | 1 | 1 |
| Steve A. Krognes | 1 | 1 |
| Jack Taunton | 1 | 1 |
| Lawrence E. Corey | 1 | 1 |
| Shefali E. Agarwal | 1 | 1 |
| Andrew E. Allen | 1 | 1 |
| Vassiliki Economides | 1 | 1 |
| Wendell Lim | 1 | 1 |
| Peter Joost | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.